Bin Li

6PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Jianjun Qin, Liyan Xue, Anlin Hao

|May 23, 2023
Short-term outcomes of robot-assisted versus thoracoscopic-assisted Mckeown esophagectomy.

Yu-Qi Meng, Bin Li, Cheng Wang

|Oct 04, 2022
Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells.

Xuan Li, Sen Zhu, Zheng Li

|Jul 15, 2022
SYNGR2 serves as a prognostic biomarker and correlates with immune infiltrates in esophageal squamous cell carcinoma.

Bin Li, Mei-Yu Ren, Yu-Zhen Chen

|Nov 09, 2019
Clinicopathological and prognostic significance of epithelial cell transforming sequence 2 expression in cancers: a systematic review and meta-analysis.

Bin Li, Jun-Ping Lin, Zheng Li

|Feb 24, 2019
Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion.

Bin Li, Tie-Niu Song, Fu-Rong Wang

Pageof 1

Frequent Collaborators

1 joint publications

Yu-Qi Meng

1 joint publications

Xiaofeng Guo

1 joint publications

Lijie Tan

1 joint publications

Zhigang Li